|
| (R)-1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutylboronic acid Basic information |
| (R)-1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutylboronic acid Chemical Properties |
Melting point | >142°C (subl.) | density | 1.306 | storage temp. | -20°C Freezer | solubility | DMSO (Sparingly), Methanol (Slightly) | form | Solid | pka | 9.67±0.43(Predicted) | color | White to Pale Yellow |
| (R)-1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutylboronic acid Usage And Synthesis |
Uses | Ixazomib is a proteasome inhibitor that acts by preventing cell growth in solid tumours. It is an anticancer agent that is used to treat patients with multiple myeloma and is potentially neurotoxic. | Definition | ChEBI: A glycine derivative that is the amide obtained by formal condensation of the carboxy group of N-(2,5-dichlorobenzoyl)glycine with the amino group of [(1R)-1-amino-3-methylbutyl]boronic acid. The active metabolite of ixa
omib citrate, it is used in combination therapy for treatment of multiple myeloma. | target | chymotrypsin-like proteolytic (β5) site of the 20S proteasome |
| (R)-1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutylboronic acid Preparation Products And Raw materials |
|